Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Keytruda
since
auto-detected in 2 stories
37 days ago
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit ⊕
Merck said its narrowed profit guidance reflects several new items, including "lower estimated costs related to the impact of tariffs."
page 1 of 1